| Dr Alejandro Murcia, MD | |
|
483 W Middle Tpke, Suite 300, Manchester, CT 06040-3863 | |
| (860) 430-1213 | |
| (860) 533-3420 |
| Full Name | Dr Alejandro Murcia |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 483 W Middle Tpke, Manchester, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114987377 | NPI | - | NPPES |
| 001206275 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 20627 (Connecticut) | Primary |
| 207RI0200X | Internal Medicine - Infectious Disease | MD7723 (District Of Columbia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alejandro Murcia, MD Po Box 1685, Manchester, CT 06045-1685 Ph: (860) 430-1213 | Dr Alejandro Murcia, MD 483 W Middle Tpke, Suite 300, Manchester, CT 06040-3863 Ph: (860) 430-1213 |
News Archive
Researchers from Tel Aviv University describe experiments that could lead to a new approach for treating Parkinson's disease using a common sweetener, mannitol.
Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2009. Dyax will host a webcast and conference call at 10 a.m. (ET) this morning to review the financial results and corporate progress for the quarter.
Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Reducing the amount of alcoholic beverages consumed, even for light-to-moderate drinkers, may improve cardiovascular health, including a reduced risk of coronary heart disease, lower body mass index (BMI) and blood pressure, according to a new multi-center study published in The BMJ and co-led by the Perelman School of Medicine at the University of Pennsylvania.
› Verified 5 days ago
Dr. Joseph Francis Mclaughlin, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Haynes St, Second Floor, Manchester, CT 06040 Phone: 860-646-0670 Fax: 860-643-9388 | |
Prof. Hazar Dahhan, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 201 Main St, Manchester, CT 06042 Phone: 860-643-5443 Fax: 860-643-9399 | |
Dr. Sun King Wan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 257 E Center St, Manchester, CT 06040 Phone: 860-643-5101 Fax: 860-533-9747 | |
Dr. Angelee Carta, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 515 Middle Tpke W, Manchester, CT 06040 Phone: 860-533-4176 Fax: 860-649-5092 | |
Dr. Joseph Hanna, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 18 Haynes St, Manchester, CT 06040 Phone: 860-649-7557 | |
Peter S Buch, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 353 Main St, Manchester, CT 06040 Phone: 860-649-3477 Fax: 860-649-0011 |